AmpliSeq for Illumina BRCA Panel

Targeted research panel investigating somatic and germline variants in BRCA1 and BRCA2.Read More...
Select Product(s)
What products do I need?
Panel

AmpliSeq™ BRCA Panel for Illumina®

20019168

Price
 
 

Library Prep

AmpliSeq™ Library PLUS (24 Reactions) for Illumina®

20019101

Price
 
 

AmpliSeq™ Library PLUS (96 Reactions) for Illumina®

20019102

Price
 
 

AmpliSeq™ Library PLUS (384 Reactions) for Illumina®

20019103

Price
 
 

Index Adapters

AmpliSeq™ CD Indexes Set A for Illumina® (96 Indexes, 96 Samples)

20019105

Price
 
 
Accessory Products

AmpliSeq™ for Illumina® Direct FFPE DNA

20023378

Price
 
 

AmpliSeq™ Library Equalizer for Illumina®

20019171

Price
 
 

Product Highlights

The AmpliSeq for Illumina BRCA Panel is a targeted resequencing assay for research of somatic and germline variants across BRCA1 and BRCA2 genes. Key features include:

Relevant Gene Content
  • Target all exonic regions and flanking intronic sequences of BRCA1 and BRCA2
Fast, Streamlined Workflow
  • Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality or 10 ng of formalin-fixed, paraffin-embedded (FFPE) input samples
Accurate Data
  • Detect somatic mutations as low as 5% variant allele frequency using local or cloud based analysis

The BRCA Panel is part of an integrated workflow that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis.

BRCA1 and BRCA2 are human tumor suppressor genes that, when carrying specific mutations, have been implicated in an increased risk for breast and ovarian cancers. This ready-to-use panel saves researchers the time and effort of identifying targets, designing primers, and optimizing panels.

Learn More About AmpliSeq for Illumina

Specifications

Method-Specific Workflow Example

 

Related Products

TruSight Cancer

These expert-defined sequencing panels target 94 genes and 284 SNPs associated with a predisposition towards various cancers.


AmpliSeq for Illumina Custom DNA Panel

Targeted custom research panels optimized for sequencing specific targets or genomic content of interest.


TruSight Tumor 170

Comprehensive next-generation sequencing (NGS) assay that targets DNA and RNA variants from the same FFPE sample.